These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

157 related items for PubMed ID: 9247311

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Molecular analysis of surgical margins in head and neck squamous cell carcinoma patients.
    Nathan CO, Amirghahri N, Rice C, Abreo FW, Shi R, Stucker FJ.
    Laryngoscope; 2002 Dec; 112(12):2129-40. PubMed ID: 12461330
    [Abstract] [Full Text] [Related]

  • 3. Correlation of p53 and the proto-oncogene eIF4E in larynx cancers: prognostic implications.
    Nathan CO, Sanders K, Abreo FW, Nassar R, Glass J.
    Cancer Res; 2000 Jul 01; 60(13):3599-604. PubMed ID: 10910074
    [Abstract] [Full Text] [Related]

  • 4. Pattern of amplification and overexpression of the eukaryotic initiation factor 4E gene in solid tumor.
    Sorrells DL, Meschonat C, Black D, Li BD.
    J Surg Res; 1999 Jul 01; 85(1):37-42. PubMed ID: 10383835
    [Abstract] [Full Text] [Related]

  • 5. Analysis of surgical margins with the molecular marker eIF4E: a prognostic factor in patients with head and neck cancer.
    Nathan CO, Franklin S, Abreo FW, Nassar R, De Benedetti A, Glass J.
    J Clin Oncol; 1999 Sep 01; 17(9):2909-14. PubMed ID: 10561370
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Molecular diagnosis of surgical margins and local recurrence in head and neck cancer patients: a prospective study.
    van Houten VM, Leemans CR, Kummer JA, Dijkstra J, Kuik DJ, van den Brekel MW, Snow GB, Brakenhoff RH.
    Clin Cancer Res; 2004 Jun 01; 10(11):3614-20. PubMed ID: 15173067
    [Abstract] [Full Text] [Related]

  • 8. [The molecular marker eIF4E in the surgical margins of the resection preparations of head-neck tumors as a prognostic factor].
    Ernst-Stecken A.
    Strahlenther Onkol; 2000 Aug 01; 176(8):383-4. PubMed ID: 10987024
    [No Abstract] [Full Text] [Related]

  • 9. A prospective trial on initiation factor 4E (eIF4E) overexpression and cancer recurrence in node-negative breast cancer.
    Holm N, Byrnes K, Johnson L, Abreo F, Sehon K, Alley J, Meschonat C, Md QC, Li BD.
    Ann Surg Oncol; 2008 Nov 01; 15(11):3207-15. PubMed ID: 18719964
    [Abstract] [Full Text] [Related]

  • 10. Up-regulation of TLK1B by eIF4E overexpression predicts cancer recurrence in irradiated patients with breast cancer.
    Wolfort R, de Benedetti A, Nuthalapaty S, Yu H, Chu QD, Li BD.
    Surgery; 2006 Aug 01; 140(2):161-9. PubMed ID: 16904965
    [Abstract] [Full Text] [Related]

  • 11. Expression of eIF4E during head and neck tumorigenesis: possible role in angiogenesis.
    Nathan CO, Franklin S, Abreo FW, Nassar R, de Benedetti A, Williams J, Stucker FJ.
    Laryngoscope; 1999 Aug 01; 109(8):1253-8. PubMed ID: 10443829
    [Abstract] [Full Text] [Related]

  • 12. Mutated p53 as a molecular marker for the diagnosis of head and neck cancer.
    van Houten VM, Tabor MP, van den Brekel MW, Kummer JA, Denkers F, Dijkstra J, Leemans R, van der Waal I, Snow GB, Brakenhoff RH.
    J Pathol; 2002 Dec 01; 198(4):476-86. PubMed ID: 12434417
    [Abstract] [Full Text] [Related]

  • 13. Genetically altered fields as origin of locally recurrent head and neck cancer: a retrospective study.
    Tabor MP, Brakenhoff RH, Ruijter-Schippers HJ, Kummer JA, Leemans CR, Braakhuis BJ.
    Clin Cancer Res; 2004 Jun 01; 10(11):3607-13. PubMed ID: 15173066
    [Abstract] [Full Text] [Related]

  • 14. Eukaryotic initiation factor 4E overexpression in triple-negative breast cancer predicts a worse outcome.
    Flowers A, Chu QD, Panu L, Meschonat C, Caldito G, Lowery-Nordberg M, Li BD.
    Surgery; 2009 Aug 01; 146(2):220-6. PubMed ID: 19628077
    [Abstract] [Full Text] [Related]

  • 15. Detection of the proto-oncogene eIF4E in larynx and hypopharynx cancers.
    Franklin S, Pho T, Abreo FW, Nassar R, De Benedetti A, Stucker FJ, Nathan CO.
    Arch Otolaryngol Head Neck Surg; 1999 Feb 01; 125(2):177-82. PubMed ID: 10037284
    [Abstract] [Full Text] [Related]

  • 16. Outcome of Patients With Head and Neck Squamous Cell Carcinoma Can be Predicted by Expression of eIF4E and Osteopontin in Free Surgical Margins.
    Abouhashem NS, Elwan A, Elaidy NF.
    Appl Immunohistochem Mol Morphol; 1999 Feb 01; 30(5):e40-e49. PubMed ID: 35285458
    [Abstract] [Full Text] [Related]

  • 17. Tetranucleotide microsatellite instability in surgical margins for prediction of local recurrence of head and neck squamous cell carcinoma.
    Temam S, Casiraghi O, Lahaye JB, Bosq J, Zhou X, Julieron M, Mamelle G, Lee JJ, Mao L, Luboinski B, Benard J, Janot F.
    Clin Cancer Res; 2004 Jun 15; 10(12 Pt 1):4022-8. PubMed ID: 15217934
    [Abstract] [Full Text] [Related]

  • 18. Expression of eukaryotic initiation factor 4E in gastric adenocarcinoma and its association with clinical outcome.
    Chen CN, Hsieh FJ, Cheng YM, Lee PH, Chang KJ.
    J Surg Oncol; 2004 Apr 01; 86(1):22-7. PubMed ID: 15048676
    [Abstract] [Full Text] [Related]

  • 19. Overexpression of eukaryotic initiation factor 4E (eIF4E) in breast carcinoma.
    Li BD, Liu L, Dawson M, De Benedetti A.
    Cancer; 1997 Jun 15; 79(12):2385-90. PubMed ID: 9191527
    [Abstract] [Full Text] [Related]

  • 20. Correlation of TLK1B in elevation and recurrence in doxorubicin-treated breast cancer patients with high eIF4E overexpression.
    Byrnes KW, DeBenedetti A, Holm NT, Luke J, Nunez J, Chu QD, Meschonat C, Abreo F, Johnson LW, Li BD.
    J Am Coll Surg; 2007 May 15; 204(5):925-33; discussion 933-4. PubMed ID: 17481512
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.